Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Mitochondrial metabolic reprogramming in CRC: mechanisms of therapy resistance and emerging interventions As discussed above, CRC cells adapt to hypoxia, nutrient deprivation, and therapeutic stress through mitochondrial metabolic reprogramming, which maintains redox homeostasis and organelle quality control to promote survival
Collectively, these results suggested that APR-017 and LCS3 treatment induce vulnerability of VRK2-deficient PC cells by GSH inhibition and consequent disruption of the balance between ROS generation and antioxidation
[1] Do not store the pen in the freezer or freezer compartment
While conventional treatments for SFN primarily focus on symptom management with medications like gabapentin, pregabalin, or duloxetine, many patients continue to suffer despite these interventions
These guidelines, however, do not give a preference regarding which of the second-line agentswhich also include sulfonylureas (SU), dipeptidyl peptidase-4 inhibitors (DPP-IV), sodium-glucose cotransporter 2 inhibitors (SGLT-2i), insulin, thiazolidinediones (TZD) and acarboseshould be added to optimised metformin [13, 14]
US$ 24.20
US$ 28.54
US$ 26.28
US$ 22.69
US$ 24.34
US$ 25.60
US$ 21.17
